Browse > Article
http://dx.doi.org/10.15324/kjcls.2019.51.3.351

Influences of the Global Deterioration Scale according to Routine Blood Chemistry Results  

Kim, Sun-Gyu (Department of Laboratory Medicine, Gyeonggi Province Medical Center Ansung Hospital)
Park, Chang-Eun (Department of Biomedical Laboratory Science, Molecular Diagnostics Research Institute, Namseoul University)
Publication Information
Korean Journal of Clinical Laboratory Science / v.51, no.3, 2019 , pp. 351-359 More about this Journal
Abstract
Neurocognitive testing commonly uses the MMSE (Mini-Mental State Examination) to evaluate the overall cognitive function of patients at outpatient clinics, but the MMSE has recently been extensively used in the SNSB II (Seoul Neuropsychological Screening Battery II) for making diagnoses. We retrospectively investigated the results of routine neurocognitive tests and the results of the blood tests of 120 elderly patients who had been referred to a South Central Medical Center from 2017 to 2018 and who had been examined at a public health center. These subjects' space-time capability was high on the sub-region of the global deterioration scale (GDS). GDS showed a significant increase as the Na decreased on the electrolyte analysis. The subjects' concentration, their language-based orientation for space and time, their memory, and their scores for the frontal lobe function on GDS showed statistically significant reductions (P<0.001) For the normal and abnormal groups according to the ALT and creatinine levels, the frontal/execute function areas showed statistically significant differences (P<0.001) as well as negative correlation between GDS and ALT (P<0.01). In conclusion, this study provides basic information to develop test items that are important for patient screening and diagnosis, and several routine blood chemistry factors provide basic information for diagnosing and assessing the status and progress of cognitively impaired patients.
Keywords
Alanine aminotransferase; Creatinine; Global deterioration scale; Seoul neuropsychological screening battery-II; Sodium;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Zetterberg H, Burnham SC. Blood-based molecular biomarkers for Alzheimer's disease. Mol Brain. 2019;12:26. https:// doi.org/10.1186/s13041-019-0448-1.   DOI
2 Kieboom BCT, Licher S, Wolters FJ, Ikram MK, Hoorn EJ, Zietse R, et al. Serum magnesium is associated with the risk of dementia. Neurology. 2017;89:1716-1722. https://doi.org/10.1212/ WNL.0000000000004517.   DOI
3 Shen Y, Ye B, Chen P, Wang Q, Fan C, Shu Y, et al. Cognitive decline, dementia, Alzheimer's disease and presbycusis: examination of the possible molecular mechanism. Front Neurosci. 2018;12:394. https://doi.org/10.3389/fnins.2018.00394.   DOI
4 Khan AA, Quinn TJ, Hewitt J, Fan Y, Dawson J. Serum uric acid level and association with cognitive impairment and dementia: systematic review and meta-analysis. Age (Dordr). 2016;38:16. https://doi.org/10.1007/s11357-016-9871-8.   DOI
5 Beydoun MA, Beydoun HA, Gamaldo AA, Teel A, Zonderman AB, Wang Y. Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis. BMC Public Health. 2014;14:643. https://doi.org/10.1186/1471-2458-14-643.   DOI
6 Vintimilla RM, Large SE, Gamboa A, Rohlfing GD, O'Jile JR, Hall JR, et al. The link between potassium and mild cognitive impairment in Mexican-Americans. Dement Geriatr Cogn Dis Extra. 2018;8:151-157. https://doi.org/10.1159/000488483.   DOI
7 Wang HX, MacDonald SW, Dekhtyar S, Fratiglioni L. Association of lifelong exposure to cognitive reserve-enhancing factors with dementia risk: a community-based cohort study. PLoS Med. 2017;14:E1002251.   DOI
8 Kang Y, Na DL, Hahn S. A validity study on the Korean mini-mental state examination (K-MMSE) in dementia patients. J Korean Neuropsychiatr Assoc. 1997;15:300-308.
9 Kim JM, Prince MJ, Shin IS, Yoon JS. Validity of Korean form of Geriatric depression scale (KGDS) among cognitively impaired Korean elderly and development of a 15-item short version (KGDS-15). Int J Met Psychiatr Res. 2001;10:204-210. https://doi.org/10.1002/mpr.117.   DOI
10 Kim JM, Shin IS, Yoon JS, Lee HY. Comparison of diagnostic validities between MMSE-K and K-MMSE for screening of dementia. J Korean Neuropsychiatr Assoc. 2002;42:124-130.
11 Oh E, Kang Y, Shin JH, Yeon BK. A validity study of K-MMSE as a screening test for dementia: comparison against a comprehensive neuropsychological evaluation. Dement Neurocognitive Disord. 2010;9:8-12.
12 Hoops S, Nazem S, Siderowf AD, Duda JE, Xie SX, Stern MB, et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology. 2009;73:1738-1745.   DOI
13 Svensson T, Sawada N, Mimura M, Nozaki S, Shikimoto R, Tsugane S. The association between midlife serum high-density lipoprotein and mild cognitive impairment and dementia after 19 years of follow-up. Transl Psychiatry. 2019;9:26. https://doi.org/10.1038/s41398-018-0336-y.   DOI
14 Sheline Y, Kehr C. Cost and utility of routine admission laboratory testing for psychiatric inpatients. Gen Hosp Psychiatry. 1990 ;12:329-34.   DOI
15 Mills JH, Megerian CA, et al. Presbyacusis and presbyastasis. In: Snow JB, Wackym, editors. Ballenger's manual of otorhinolaryngology head and neck surgery. 17th ed. Shelton: People's medical publishing house; 2009. p333-343.
16 Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. Lancet. 2017;390:2673-2734. https://doi.org/10.1016/S0140-6736 (17)31363-31366.   DOI
17 Ozawa M, Ninomiya T, Ohara T, Hirakawa Y, Doi Y, Hata J, et al, Self-reported dietary intake of potassium, calcium, and magnesium and risk of dementia in the Japanese: the Hisayama Study. J Am Geriatr Soc. 2012;60:1515-1520.   DOI
18 Sims Wright R, Levy SA, Katzel LI, Rosenberger WF, Manukyan Z, Whitfield KE. Fasting glucose and glucose tolerance as potential predictors of neurocognitive function among nondiabetic older adults. J Clin Exp Neuropsychol. 2015;37:49-60. https://doi.org/10.1080/13803395.2014.985189.   DOI
19 Anfinson TJ, Kathol RG. Screening laboratory evaluation in psychiatric patients: a review. Gen Hosp Psychiatry. 1992;14:248-257.   DOI
20 Reisberg B, Ferris SH, de Leon MJ, Crook T. The global deterioration scale (GDS) for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139:1136-1139. https://doi.org/10.1176/ajp.139.9.1136.   DOI
21 Hyman BT. New neuropathological criteria for Alzheimer disease. Arch Neurol. 1998;55:1174-1176. https://doi.org/10.1001/ archneur.55.9.1174.   DOI
22 Heller S, Steinberg A, Sedler M. Validation of the english version of the multimodal assessment of capacities in severe dementia (MAC-SD): A cognitive and functional scale for use in severe dementia. J Alzheimers Dis Rep. 2017;1:249-262. https:// doi.org/10.3233/ADR-170038.   DOI
23 Tsigelny IF, Crews L, Desplats P, Shaked GM, Sharikov Y, Mizuno H, et al. Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases. PLoS One 2008;3:e3135. https:// doi.org/10.1371/journal.pone.0003135.   DOI
24 Gallardo G, Schluter OM, Sudhof TC. A molecular pathway of neurodegeneration linking alpha-synuclein to Apo E and A beta peptides. Nat Neurosci. 2008;11:301-308.   DOI
25 Choi SH, Na DL, Lee BH, Hahm D, Jeong JH, Yoon SJ, et al. Estimating the validity of the Korean version of expanded Clinical Dementia Rating (CDR) Scale. J Korean Neurol Assoc. 2001;19:585-591.